Champions Oncology (CSBR) Proxy Filing summary

Executive summary

• Annual Meeting scheduled for October 16, 2025, to elect seven directors, ratify the auditor, and approve executive compensation on an advisory basis.

• Record date for voting is August 22, 2025, with 13,788,421 shares outstanding.

• Proxy materials are available online, and shareholders are encouraged to vote electronically or by mail.

Voting matters and shareholder proposals

• Shareholders will vote on electing seven director nominees, ratifying EisnerAmper LLP as auditor for FY 2026, and a non-binding say-on-pay resolution for executive compensation.

• Board recommends voting FOR all proposals.

• Other business may be transacted as appropriate.

Board of directors and corporate governance

• Seven nominees, all current directors, with detailed backgrounds in healthcare, finance, and technology.

• Five directors are independent under Nasdaq rules.

• Board met twice in FY 2025; all directors attended at least 75% of meetings.

• Committees: Audit, Compensation, and Nominating & Corporate Governance, each with independent members.

• Leadership structure separates CEO and Chairman roles.

• Code of Ethics and communication channels for shareholders are established.